[HTML][HTML] Current progress in dengue vaccines

SW Wan, CF Lin, S Wang, YH Chen, TM Yeh… - Journal of biomedical …, 2013 - Springer
Dengue is one of the most important emerging vector-borne viral diseases. There are four
serotypes of dengue viruses (DENV), each of which is capable of causing self-limited …

Dengue vaccine development: strategies and challenges

L Ramakrishnan, M Radhakrishna Pillai… - Viral immunology, 2015 - liebertpub.com
Infection with dengue virus may result in dengue fever or a more severe outcome, such as
dengue hemorrhagic syndrome/shock. Dengue virus infection poses a threat to endemic …

Dengue virus vaccine development

LE Yauch, S Shresta - Advances in virus research, 2014 - Elsevier
Dengue virus (DENV) is a significant cause of morbidity and mortality in tropical and
subtropical regions, causing hundreds of millions of infections each year. Infections range …

Dengue vaccines: progress and challenges

BAG Coller, DE Clements - Current opinion in immunology, 2011 - Elsevier
With several dengue vaccine candidates progressing through clinical trials, several options
for controlling this disease appear feasible. This would represent a major achievement and …

[HTML][HTML] Dengue fever: causes, complications, and vaccine strategies

N Khetarpal, I Khanna - Journal of immunology research, 2016 - hindawi.com
Dengue is a highly endemic infectious disease of the tropical countries and is rapidly
becoming a global burden. It is caused by any of the 4 serotypes of dengue virus and is …

Current issues in dengue vaccination

SJ Thomas, TP Endy - Current opinion in infectious diseases, 2013 - journals.lww.com
Current issues in dengue vaccination : Current Opinion in Infectious Diseases Current issues
in dengue vaccination : Current Opinion in Infectious Diseases Log in or Register Subscribe …

[HTML][HTML] A review on dengue vaccine development

SQ Deng, X Yang, Y Wei, JT Chen, XJ Wang, HJ Peng - Vaccines, 2020 - mdpi.com
Dengue virus (DENV) has become a global health threat with about half of the world's
population at risk of infection. Although the disease caused by DENV is self-limiting in the …

Challenges on the development of a dengue vaccine: a comprehensive review of the state of the art

J Pintado Silva… - Journal of General …, 2023 - microbiologyresearch.org
Dengue virus (DENV) is the mosquito-borne virus of greatest human health concern. There
are four serotypes of DENV (1-4) that co-circulate in endemic areas. Each serotype of DENV …

Vaccines licensed and in clinical trials for the prevention of dengue

J Torresi, G Ebert, M Pellegrini - Human vaccines & …, 2017 - Taylor & Francis
Dengue has become a major global public health threat with almost half of the world's
population living in at-risk areas. Vaccination would likely represent an effective strategy for …

Dengue vaccine: an update

CH Huang, YT Tsai, SF Wang, WH Wang… - Expert Review of Anti …, 2021 - Taylor & Francis
Introduction: Dengue virus is a global health threat, with approximately 390 million dengue
infections annually. Efficient vaccines for dengue prevention are currently lacking. This …